Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden · Delayed Price · Currency is SEK 5.17
+0.05 (0.98%)
Feb 10, 2026, 5:29 PM CET
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 2.02 billion as of February 10, 2026. Its market cap has decreased by -8.12% in one year.
Market Cap
2.02B
Enterprise Value
1.97B
Revenue
55.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.17
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 2.02B, an increase of 799.65%. That is a compound annual growth rate of 15.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 2.02B | -4.12% |
| Dec 30, 2025 | 2.11B | -16.09% |
| Dec 30, 2024 | 2.51B | 54.03% |
| Dec 29, 2023 | 1.63B | 7.15% |
| Dec 30, 2022 | 1.52B | 37.56% |
| Dec 30, 2021 | 1.11B | -10.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.69B |
| Saniona AB | 3.35B |
| Vicore Pharma Holding AB | 2.91B |
| Flerie AB | 2.77B |
| Diamyd Medical AB | 2.25B |
| BioInvent International AB | 1.71B |
| Genovis AB (publ.) | 1.35B |
| Cantargia AB | 1.32B |